M M Okun - JoVE Visualize

Showing results (11-20 of 12) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 12 results.

The British Journal of Dermatology|March 28, 2019

Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: integrated results from the phase III randomized placebo-controlled PIONEER trialsG B E Jemec, M M Okun, S B Forman, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV|August 10, 2016

Efficacy and safety of adalimumab in Chinese patients with moderate-to-severe plaque psoriasis: results from a phase 3, randomized, placebo-controlled, double-blind studyL Cai, J Gu, J Zheng, et al.

Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 12 results.

The British Journal of Dermatology|March 28, 2019

Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: integrated results from the phase III randomized placebo-controlled PIONEER trialsG B E Jemec, M M Okun, S B Forman, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV|August 10, 2016

Efficacy and safety of adalimumab in Chinese patients with moderate-to-severe plaque psoriasis: results from a phase 3, randomized, placebo-controlled, double-blind studyL Cai, J Gu, J Zheng, et al.

Pageof 2